Impact of the preoperative bone mineral density on the outcomes after resection of pancreatic cancer



The aim of this study is to evaluate the correlation between bone mineral density (BMD) and other body composition markers, as well as, the impact of preoperative BMD on the surgical outcomes after resection of pancreatic cancer.


This retrospective study included 275 patients who underwent surgical resection of pancreatic cancer in our institute between 2003 and 2016. Patients were divided according to BMD into low and normal groups and their postoperative outcomes were compared. Risk factors for mortality and tumor recurrence were also evaluated.


Patients with low BMD were older (P < 0.001), had a higher intramuscular adipose tissue content (P = 0.011) and higher visceral fat area (P = 0.003). The incidence of postoperative pancreatic fistula (POPF) (grade ≥ B) was higher in the low BMD group. No significant difference was observed between the two groups regarding overall survival and recurrence-free survival and low BMD was not a risk factor for mortality or tumor recurrence after resection of pancreatic cancer.


A low preoperative BMD was not found to be a risk factor for mortality or tumor recurrence after resection of pancreatic cancer; however, it was associated with a higher incidence of clinically relevant POPF.

This is a preview of subscription content, log in to check access.

Access options

Buy single article

Instant unlimited access to the full article PDF.

US$ 39.95

Price includes VAT for USA

Subscribe to journal

Immediate online access to all issues from 2019. Subscription will auto renew annually.

US$ 99

This is the net price. Taxes to be calculated in checkout.

Fig. 1
Fig. 2



Body mass index


Bone mineral density

CA 19.9:

Carbohydrate antigen 19.9


Computed tomography


Distal pancreatectomy


Dual-energy X-ray absorptiometry


Hazard ratio


Hepatocellular carcinoma


Hounsfield unit


Intramuscular adipose tissue content


Interquartile range


Modified Glasgow prognostic score


Neoadjuvant chemotherapy


Overall survival




Psoas muscle index


Prognostic nutritional index


Postoperative pancreatic fistula


Recurrence-free survival


Skeletal mass index


Union for International Cancer Control


Visceral to subcutaneous adipose tissue area ratio


  1. 1.

    Ilic M, Ilic I. Epidemiology of pancreatic cancer. World J Gastroenterol. 2016;22:9694–705.

  2. 2.

    Okumura S, Kaido T, Hamaguchi Y, Kobayashi A, Shirai H, Yao S, et al. Visceral adiposity and sarcopenic visceral obesity are associated with poor prognosis after resection of pancreatic cancer. Ann Surg Oncol. 2017;24:3732–40.

  3. 3.

    Reynolds RB, Folloder J. Clinical management of pancreatic cancer. J Adv Pract Oncol. 2014;5:356–64.

  4. 4.

    Kaido T, Ogawa K, Fujimoto Y, Ogura Y, Hata K, Ito T, et al. Impact of sarcopenia on survival in patients undergoing living donor liver transplantation. Am J Transplant. 2013;13:1549–56.

  5. 5.

    Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yagi S, et al. Impact of skeletal muscle mass index, intramuscular adipose tissue content, and visceral to subcutaneous adipose tissue area ratio on early mortality of living donor liver transplantation. Transplantation. 2017;101:565–74.

  6. 6.

    Hamaguchi Y, Kaido T, Okumura S, Fujimoto Y, Ogawa K, Mori A, et al. Impact of quality as well as quantity of skeletal muscle on outcomes after liver transplantation. Liver Transplant. 2014;20:1413–9.

  7. 7.

    Peng P, Hyder O, Firoozmand A, Kneuertz P, Schulick RD, Huang D, et al. Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma. J Gastrointest Surg. 2012;16:1478–86.

  8. 8.

    Levolger S, Ijzermans JNM, Ayez N, Tran TCK, Verhoef C, van Vledder MG. Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg. 2012;99:550–7.

  9. 9.

    Okumura S, Kaido T, Hamaguchi Y, Fujimoto Y, Masui T, Mizumoto M, et al. Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer. Surgery. 2015;157:1088–98.

  10. 10.

    Verschueren S, Gielen E, O’Neill TW, Pye SR, Adams JE, Ward KA, et al. Sarcopenia and its relationship with bone mineral density in middle-aged and elderly European men. Osteoporos Int. 2013;24:87–988.

  11. 11.

    Pereira FB, Leite AF, de Paula AP. Relationship between pre-sarcopenia, sarcopenia and bone mineral density in elderly men. Arch Endocrinol Metab. 2015;59:59–655.

  12. 12.

    Schreiber JJ, Anderson PA, Rosas HG, Buchholz AL, Au AG. Hounsfield units for assessing bone mineral density and strength: a tool for osteoporosis management. J Bone Jt Surg Ser A. 2011;93:1057–63.

  13. 13.

    Yao S, Kaido T, Okumura S, Iwamura S, Miyachi Y, Shirai H, et al. Bone mineral density correlates with survival after resection of extrahepatic biliary malignancies. Clin Nutr. 2018;38:2770–7.

  14. 14.

    Miyachi Y, Kaido T, Yao S, Shirai H, Kobayashi A, Hamaguchi Y, et al. Bone mineral density as a risk factor for patients undergoing surgery for hepatocellular carcinoma. World J Surg. 2019;43:920–8.

  15. 15.

    Sun K, Chen S, Xu J, Li G, He Y. The prognostic significance of the prognostic nutritional index in cancer: a systematic review and meta-analysis. J Cancer Res Clin Oncol. 2014;140:1537–49.

  16. 16.

    Proctor MJ, Morrison DS, Talwar D, Balmer SM, O’Reilly DSJ, Foulis AK, et al. An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study. Br J Cancer. 2011;104:726–34.

  17. 17.

    Dindo D, Demartines N, Clavien P-A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.

  18. 18.

    Dervenis C, Izbicki J, Neoptolemos J, Bassi C, Butturini G, Yeo C, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138:8–13.

  19. 19.

    Sharma P, Parikh ND, Yu J, Barman P, Derstine BA, Sonnenday CJ, et al. Bone mineral density predicts posttransplant survival among hepatocellular carcinoma liver transplant recipients. Liver Transplant. 2016;22:1092–8.

  20. 20.

    Richards JB, Rivadeneira F, Inouye M, Pastinen TM, Soranzo N, Wilson SG, et al. Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet (London, England). 2008;371:1505–12.

  21. 21.

    Marinova M, Edon B, Wolter K, Katsimbari B, Schild HH, Strunk HM. Use of routine thoracic and abdominal computed tomography scans for assessing bone mineral density and detecting osteoporosis. Curr Med Res Opin. 2015;31:1871–81.

  22. 22.

    Brett AD, Brown JK. Quantitative computed tomography and opportunistic bone density screening by dual use of computed tomography scans. J Orthop Transl. 2015;3:178–84.

  23. 23.

    Gausden EB, Nwachukwu BU, Schreiber JJ, Lorich DG, Lane JM. Opportunistic use of CT imaging for osteoporosis screening and bone density assessment. J Bone Jt Surg. 2017;99:1580–90.

  24. 24.

    Ziemlewicz TJ, Binkley N, Pickhardt PJ. Opportunistic osteoporosis screening: addition of quantitative CT bone mineral density evaluation to CT colonography. J Am Coll Radiol. 2015;12:1036–41.

  25. 25.

    Reuss-Borst M, Hartmann U, Scheede C, Weiß J. Prevalence of osteoporosis among cancer patients in Germany: prospective data from an oncological rehabilitation clinic. Osteoporos Int. 2012;23:1437–44.

  26. 26.

    Axelsen CT, Jensen AB, Jakobsen EH, Bechmann T. Bone loss during neoadjuvant/adjuvant chemotherapy for early stage breast cancer: a retrospective cohort study. Mol Clin Oncol. 2018;8:767.

  27. 27.

    Chen Y, Xu G, Yang F. Effect of neoadjuvant chemotherapy on the serum levels of bone turnover markers in women with early-stage breast cancer. PLoS ONE. 2015;10:e0126053.

  28. 28.

    Lee H-F, Wu C-E, Lin Y-S, Hwang J-S, Wu C-H, Chu P-H. Low bone mineral density may be associated with long-term risk of cancer in the middle-aged population: a retrospective observational study from a single center. J Formos Med Assoc. 2018;117:339–45.

  29. 29.

    Tanishima S, Morio Y. A review of minodronic acid hydrate for the treatment of osteoporosis. Clin Interv Aging. 2013;8:185.

  30. 30.

    Bolam KA, van Uffelen JGZ, Taaffe DR. The effect of physical exercise on bone density in middle-aged and older men: a systematic review. Osteoporos Int. 2013;24:2749–62.

  31. 31.

    Szulc P, Beck TJ, Marchand F, Delmas PD. Low skeletal muscle mass is associated with poor structural parameters of bone and impaired balance in elderly men—the MINOS study. J Bone Miner Res. 2004;20:721–9.

  32. 32.

    Nahm CB, Connor SJ, Samra JS, Mittal A. Postoperative pancreatic fistula: a review of traditional and emerging concepts. Clin Exp Gastroenterol. 2018;11:105–18.

  33. 33.

    Nishida Y, Kato Y, Kudo M, Aizawa H, Okubo S, Takahashi D, et al. Preoperative sarcopenia strongly influences the risk of postoperative pancreatic fistula formation after pancreaticoduodenectomy. J Gastrointest Surg. 2016;20:1586–94.

  34. 34.

    Sato N, Tamura T, Minagawa N, Hirata K. Preoperative body mass index-to-prognostic nutritional index ratio predicts pancreatic fistula after pancreaticoduodenectomy. Hepatobiliary Surg Nutr. 2016;5:256–62.

Download references

Author information

Correspondence to Toshimi Kaido.

Ethics declarations

Conflict of interest

The authors declare no conflicts of interest in association with the present study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Sharshar, M., Kaido, T., Shirai, H. et al. Impact of the preoperative bone mineral density on the outcomes after resection of pancreatic cancer. Surg Today (2020).

Download citation


  • Bone mineral density
  • Sarcopenia
  • Pancreatic cancer
  • Survival
  • Recurrence